Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuro-Oncology

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11060-008-9734-yPMID 19023520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atypical and malignant meningiomas

  2009influential reference
• Tc-Tetrofosmin SPECT for the assessment of meningioma malignancy

  2008cited by this paper
• Evaluation of meningioma aggressiveness by (99m)Tc-Tetrofosmin SPECT.

  2008cited by this paper
• Recurrent meningioma

  2007cited by this paper
• Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas.

  2007cited by this paper
• Celecoxib inhibits meningioma tumor growth in a mouse xenograft model

  2007cited by this paper
• Cyclooxygenase-2 (COX-2) Overexpression in Meningiomas: Real Time PCR and Immunohistochemistry

  2007cited by this paper
• [A case of malignant meningioma treated by individual adjuvant chemotherapy based on the mRNA expression of drug-resistance gene].

  2007cited by this paper
• Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas.

  2007cited by this paper
• Salvage chemotherapy With CPT-11 for recurrent meningioma

  2006cited by this paper
• CALCIUM CHANNEL ANTAGONISTS AUGMENT HYDROXYUREA‐ AND RU486‐INDUCED INHIBITION OF MENINGIOMA GROWTH IN VIVO AND IN VITRO

  2006cited by this paper
• Long-Term Administration of Mifepristone (RU486): Clinical Tolerance During Extended Treatment of Meningioma

  2006cited by this paper
• Self-assessment in Neurological Surgery: The SANS Wired White Paper

  2006cited by this paper
• Hydroxyurea treatment of meningiomas: a pilot study.

  2006cited by this paper
• Atypical and Malignant Meningiomas

  2006cited by this paper
• Prolonged Oral Hydroxyurea and Concurrent 3d-Conformal Radiation in Patients with Progressive or Recurrent Meningioma: Results of a Pilot Study

  2005cited by this paper
• Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.

  2005cited by this paper
• Cerebrospinal fluid‐disseminated meningioma

  2005influential reference
• A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group study

  2005cited by this paper
• Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up

  2004cited by this paper
• Expression of G-CSF and GM-CSF in Human Meningiomas Correlates with Increased Tumor Proliferation and Vascularization

  2004cited by this paper
• Non-Resectable Slow-Growing Meningiomas Treated by Hydroxyurea

  2004cited by this paper
• Expression of Somatostatin Receptor mRNA in Human Meningiomas and their Implication in in vitro Antiproliferative Activity

  2004cited by this paper
• Lovastatin is a Potent Inhibitor of Meningioma Cell Proliferation: Evidence for Inhibition of a Mitogen Associated Protein Kinase

  2004cited by this paper
• Traitement des méningiomes par hydroxyurée

  2004cited by this paper
• Heterogeneity in the expression of markers for drug resistance in brain tumors.

  2004cited by this paper
• [Hydroxyurea treatment for unresectable meningioma].

  2004cited by this paper
• Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.

  2002cited by this paper
• Meningioma treated with interferon-α, evaluated with [11C]-L-methionine positron emission tomography

  2001cited by this paper
• Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography.

  2001cited by this paper
• Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation.

  2000cited by this paper
• Regression of a presumed meningioma with the antiestrogen agent mepitiostane. Case report.

  2000cited by this paper
• Hydroxyurea Chemotherapy for Unresectable or Residual Meningioma

  2000cited by this paper
• Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.

  2000cited by this paper
• Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.

  1997cited by this paper
• The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.

  1997cited by this paper
• [Somatostatin receptors in meningioma: diagnostic and therapeutic value].

  1997cited by this paper
• Chemotherapy for meningiomas

  1996cited by this paper
• In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists.

  1995cited by this paper
• Interferon-alfa-2b for meningioma.

  1995cited by this paper
• Role of antiprogestational therapy for meningiomas.

  1994cited by this paper
• Mifepristone (RU 486) treatment of meningiomas.

  1992cited by this paper
• Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.

  1992cited by this paper
• Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.

  1991cited by this paper
• Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha.

  1991cited by this paper
• Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristics.

  1991cited by this paper
• Somatostatin suppression of meningioma cell proliferation in vitro

  1987cited by this paper

• Benign tumors broaden the field of application for immunotherapy

  2025cites this paper
• Case Report: Advanced grade 2 meningioma with PBRM1 inactivation with prolonged response to immunotherapy

  2025cites this paper
• The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas

  2024cites this paper
• Minimally Invasive Approaches in the Surgical Treatment of Intracranial Meningiomas: An Analysis of 54 Cases

  2024cites this paper
• Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas

  2023cites this paper
• Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications

  2023cites this paper
• Quality of Life, Clinical, and Patient-Reported Outcomes after Pencil Beam Scanning Proton Therapy Delivered for Intracranial Grade WHO 1–2 Meningioma in Children and Adolescents

  2023cites this paper
• Spinal Meningiomas.

  2023cites this paper
• Metastatic Meningioma of the Neck: A Case Report and Systematic Review

  2022cites this paper
• 10 Management of Benign Skull Base Tumors in Neuro-oncology: Systemic Cytotoxic and Targeted Therapies Systemic cytotoxic and targeted therapies Benign skull base tumors in neuro-oncology

  2021cites this paper
• Liposomes: Ideal drug delivery systems in breast cancer

  2021cites this paper
• Clinical experience in the treatment of spinal cord tumors with cyberknife® fractionated stereotactic radiotherapy

  2021cites this paper
• Rhabdoid Meningioma Metastases Cervical Lymph Nodes: A Rare Clinical Case Report and Treatment Outcome

  2021cites this paper
• Meningioma

  2020cites this paper
• Gemcitabine in Recurrent Meningioma

  2020cites this paper
• Molecular characteristics of meningiomas

  2020cites this paper
• The controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review

  2020cites this paper
• Emerging Medical Treatments for Meningioma in the Molecular Era

  2018cites this paper
• Benign Intracranial Tumors.

  2018cites this paper
• Current treatment options for meningioma

  2018cites this paper
• Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology

  2018cites this paper
• Extrakraniálně metastazující meningeomy Extracranially Metastasizing Meningiomas

  2018cites this paper
• Atypical and Malignant Meningiomas

  2017cites this paper
• Genetic and epigenetic alterations in meningiomas.

  2017cites this paper
• Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base.

  2017cites this paper
• Drug Resistance in Malignant Meningiomas

  2016cites this paper
• Unresectable Recurrent Multiple Meningioma: A Case Report with Radiological Response to Somatostatin Analogues

  2016cites this paper
• Surgical Techniques in Benign Extra-Axial Tumors

  2016cites this paper
• Systemic therapy for recurrent meningioma

  2016cites this paper
• Human epidermal growth factor receptor 2/neu protein expression in meningiomas: An immunohistochemical study

  2016cites this paper
• The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas—a critical review

  2015cites this paper
• New Developments in Management of Meningioma

  2015cites this paper
• Assessment of the treatment response of spinal meningiomas after radiosurgery focusing on serial MRI findings

  2015cites this paper
• Expression of astrocyte elevated gene-1 (AEG-1) in human meningiomas and its roles in cell proliferation and survival

  2014cites this paper
• Herbal nanoparticles: A patent review

  2014cites this paper
• Advances in Diagnostic and Treatment Modalities for Intracranial Tumors

  2014cites this paper
• New treatment modalities for brain tumors in dogs and cats.

  2014cites this paper
• Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis

  2013cites this paper
• IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

  2013cites this paper
• IFN-a for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series CASE SERIES

  2013cites this paper
• Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases

  2013cites this paper
• Immunohistochemical study of MRP5 expression in meningiomas

  2013cites this paper
• Detection and quantification of farnesol-induced apoptosis in difficult primary cell cultures by TaqMan protein assay

  2013cites this paper
• Atypical meningioma: a study of prognostic factors.

  2013cites this paper
• Is there effective systemic therapy for recurrent surgery- and radiation-refractory meningioma?

  2013cites this paper
• Successful treatment of anaplastic meningioma metastatic to cervical lymph nodes

  2013cites this paper
• NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches

  2013cites this paper
• Radiosurgery of Spinal Meningiomas and Schwannomas

  2012cites this paper
• 19 – Management of recurrent gliomas and meningiomas

  2012cites this paper
• Temozolomide Combined with Radiotherapy in the Treatment of Recurrent Cranial Meningioma Previously Treated with Multiple Surgical Resections and Two Sessions of Radiosurgery: A Case Report and Literature Review

  2012cites this paper
• Radiosurgery of Spinal Meningiomas and Schwannomas

  2012cites this paper
• The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma

  2012cites this paper
• Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma

  2012cites this paper
• Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma.

  2012cites this paper
• Atypical meningioma: a study of prognostic factors.

  2012cites this paper
• Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis

  2012cites this paper
• Genetic and molecular alterations in meningiomas.

  2011cites this paper
• Adult intradural primary spinal cord tumors.

  2011cites this paper
• Treatment of unresectable skull base meningiomas with somatostatin analogs.

  2011cites this paper
• DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

  2011cites this paper
• Spinal lesions causing cord compression: a practice-related evaluation of care

  2011cites this paper
• Information needs of patients with meningiomas.

  2011cites this paper
• Management of meningiomas.

  2010cites this paper
• Behandlung irresektabler intrakranieller Meningeome mit Somatostatin-Analoga Treatment of Unresectable Intracranial Meningiomas with Somatostatin Analogues

  2010cites this paper
• Medical therapies for meningiomas

  2010cites this paper
• Cervical Lymph Node Metastases from Meningioma: Report of Two Cases and Treatment Outcome

  2010cites this paper
• Behandlung irresektabler intrakranieller Meningeome mit Somatostatin-Analoga

  2010cites this paper
• A menigothelial meningioma (WHO grade I) with malignant progression and cutaneous, pulmonary and bone metastases: a case report

  2009influential citation
• WHO grade II and III meningiomas: a study of prognostic factors

  2009cites this paper
• Usage and Distribution for Commercial Purposes Requires Written Permission. Unresectable Recurrent Multiple Meningioma: a Case Report with Radiological Response to Somatostatin Analogues Ortolá Buigues Et Al.: Unresectable Recurrent Multiple Meningioma: a Case Report with Radiological Response to So

  year unknowncites this paper